Bahitham_2016_Biochim.Biophys.Acta_1861_482

Reference

Title : Liver-specific expression of carboxylesterase 1g\/esterase-x reduces hepatic steatosis, counteracts dyslipidemia and improves insulin signaling - Bahitham_2016_Biochim.Biophys.Acta_1861_482
Author(s) : Bahitham W , Watts R , Nelson R , Lian J , Lehner R
Ref : Biochimica & Biophysica Acta , 1861 :482 , 2016
Abstract :

Ces1g/Es-x deficiency in mice results in weight gain, insulin resistance, fatty liver and hyperlipidemia through upregulation of de novo lipogenesis and oversecretion of triacylglycerol (TG)-rich lipoproteins. Here, we show that restoration of Ces1g/Es-x expression only in the liver significantly reduced hepatic TG concentration accompanied by decreased size of lipid droplets, reduced secretion of very low-density lipoproteins and improved insulin-mediated signal transduction in the liver. Collectively, these results demonstrate that hepatic Ces1g/Es-x plays a critical role in limiting hepatic steatosis, very low-density lipoprotein assembly and in augmenting insulin sensitivity.

PubMedSearch : Bahitham_2016_Biochim.Biophys.Acta_1861_482
PubMedID: 26976727
Gene_locus related to this paper: mouse-Ces1g

Related information

Gene_locus mouse-Ces1g

Citations formats

Bahitham W, Watts R, Nelson R, Lian J, Lehner R (2016)
Liver-specific expression of carboxylesterase 1g\/esterase-x reduces hepatic steatosis, counteracts dyslipidemia and improves insulin signaling
Biochimica & Biophysica Acta 1861 :482

Bahitham W, Watts R, Nelson R, Lian J, Lehner R (2016)
Biochimica & Biophysica Acta 1861 :482